Kezar Life Sciences Inc (NASDAQ: KZR) is -15.82% lower on its value in year-to-date trading and has touched a low of $0.52 and a high of $1.13 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The KZR stock was last observed hovering at around $0.83 in the last trading session, with the day’s loss setting it -0.03%.
Currently trading at $0.80, the stock is 30.32% and 30.20% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.19 million and changing -3.40% at the moment leaves the stock 4.61% off its SMA200. KZR registered -21.04% loss for a year compared to 6-month loss of 0.00%. The firm has a 50-day simple moving average (SMA 50) of $0.6154 and a 200-day simple moving average (SMA200) of $0.7621.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 37.52% gain in the last 1 month and extending the period to 3 months gives it a 45.74%, and is 46.63% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 14.85% over the week and 6.73% over the month.
Kezar Life Sciences Inc (KZR) has around 58 employees, a market worth around $58.19M and $7.00M in sales. Profit margin for the company is -1408.11%. Distance from 52-week low is 53.31% and -29.74% from its 52-week high. The company has generated returns on investments over the last 12 months (-60.68%).
with sales reaching $800k over the same period.The EPS is expected to grow by 12.44% this year, but quarterly earnings will post -71.40% year-over-year.
Kezar Life Sciences Inc (KZR) Top Institutional Holders
92.0 institutions hold shares in Kezar Life Sciences Inc (KZR), with institutional investors hold 63.47% of the company’s shares. The shares outstanding are 72.78M, and float is at 62.06M with Short Float at 1.39%. Institutions hold 54.08% of the Float.
The top institutional shareholder in the company is SUVRETTA CAPITAL MANAGEMENT, LLC with over 7.17 million shares valued at $4.3 million. The investor’s holdings represent 9.8456% of the KZR Shares outstanding. As of 2024-06-30, the second largest holder is AVIDITY PARTNERS MANAGEMENT LP with 5.03 million shares valued at $3.02 million to account for 6.9039 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 2.74 million shares representing 3.7653% and valued at over $1.64 million, while SPHERA FUNDS MANAGEMENT LTD. holds 2.8182 of the shares totaling 2.05 million with a market value of $1.23 million.
Kezar Life Sciences Inc (KZR) Insider Activity
The most recent transaction is an insider sale by Schiller Mark C., the company’s Chief Legal Officer. SEC filings show that Schiller Mark C. sold 6,688 shares of the company’s common stock on Jul 02 ’24 at a price of $0.58 per share for a total of $3879.0. Following the sale, the insider now owns 33007.0 shares.
